Hormonal Contraception and Cancer Risks
BREAST CANCER
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Breast cancer and hormonal contraceptives: collaborative reanalysis of
individual data on 53 297 women with breast cancer and 100 239 women
without breast cancer from 54 epidemiological studies. Collaborative
Group on Hormonal Factors in Breast Cancer. Lancet. Jun 22
1996;347(9017):1713-1727.
Link to PubMed
Breast cancer and hormonal contraceptives: further results. Collaborative
Group on Hormonal Factors in Breast Cancer. Contraception. Sep
1996;54(3 Suppl):1S-106S.
Link to PubMed
Contraceptive methods and breast cancer risk: an update. Contracept
Rep. Jul 2000;11(2):9-11.
Link to PubMed
Long-term oral contraceptive use and the risk of breast cancer. The
centers for Disease Control Cancer and Steroid Hormone Study. Jama.
Mar 25 1983;249(12):1591-1595.
Link to Article
Althuis MD, Brogan DR, Coates RJ, et al. Hormonal content and potency
of oral contraceptives and breast cancer risk among young women. Br J
Cancer. Jan 13 2003;88(1):50-57.
Link to PubMed
Bailie R, Katzenellenbogen J, Hoffman M, et al. A case control study of
breast cancer risk and exposure to injectable progestogen contraceptives.
Methods and patterns of use among controls. S Afr Med J. Mar
1997;87(3):302-305.
Link to PubMed
Baird DT, Glasier AF. Hormonal contraception. N Engl J Med. May 27
1993;328(21):1543-1549.
Link to PubMed
Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G. Mortality
associated with oral contraceptive use: 25 year follow up of cohort of 46
000 women from Royal College of General Practitioners' oral
contraception study. Bmj. Jan 9 1999;318(7176):96-100.
Link to PDF
Borgelt-Hansen L. Oral contraceptives: an update on health benefits and
risks. J Am Pharm Assoc (Wash). Nov-Dec 2001;41(6):875-886; quiz 925876.
Link to PubMed
Caygill CP, Hill MJ. Trends in European breast cancer incidence and
possible etiology. Tumori. Apr 30 1991;77(2):126-129.
Link to PubMed
Hormonal Contraception and Cancer Risks
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
Colditz GA, Rosner BA, Speizer FE. Risk factors for breast cancer
according to family history of breast cancer.For the Nurses' Health Study
Research Group. J Natl Cancer Inst. Mar 20 1996;88(6):365-371.
Link to PubMed
Fowke JH, Shu XO, Dai Q, et al. Oral contraceptive use and breast cancer
risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic
polymorphisms. Cancer Epidemiol Biomarkers Prev. Aug
2004;13(8):1308-1315.
Link to PDF
Gadducci A, Biglia N, Sismondi P, Genazzani AR. Breast cancer and sex
steroids: critical review of epidemiological, experimental and clinical
investigations on etiopathogenesis, chemoprevention and endocrine
treatment of breast cancer. Gynecol Endocrinol. Jun 2005;20(6):343-360.
Link to PubMed
Gast K, Snyder T. Combination oral contraceptives and cancer risk. Kans
Med. Jul 1990;91(7):201-208.
Link to PubMed
Gay JW, Cardwell MS. Oral contraceptives and breast cancer. Mo Med.
Oct 1990;87(10):763-767.
Link to PubMed
Grabrick DM, Hartmann LC, Cerhan JR, et al. Risk of breast cancer with
oral contraceptive use in women with a family history of breast cancer.
Jama. Oct 11 2000;284(14):1791-1798.
Link to PubMed
Hannaford PC, Kay CR. The risk of serious illness among oral
contraceptive users: evidence from the RCGP's oral contraceptive study.
Br J Gen Pract. Oct 1998;48(435):1657-1662.
Link to PubMed
Herbst AL, Berek JS. Impact of contraception on gynecologic cancers. Am
J Obstet Gynecol. Jun 1993;168(6 Pt 2):1980-1985.
Link to PubMed
Isaksson E, von Schoultz E, Odlind V, et al. Effects of oral contraceptives
on breast epithelial proliferation. Breast Cancer Res Treat. Jan
2001;65(2):163-169.
Link to PubMed
Johnson KH, Millard PS. Oral contraceptives and breast cancer. J Fam
Pract. Oct 1996;43(4):340-341.
Link to PubMed
Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E. Use of
oral contraceptives and breast cancer risk: The Norwegian-Swedish
Women's Lifestyle and Health Cohort Study. Cancer Epidemiol
Biomarkers Prev. Nov 2002;11(11):1375-1381.
Link to PDF
Hormonal Contraception and Cancer Risks
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
Lee NC, Rosero-Bixby L, Oberle MW, Grimaldo C, Whatley AS, Rovira
EZ. A case-control study of breast cancer and hormonal contraception in
Costa Rica. J Natl Cancer Inst. Dec 1987;79(6):1247-1254.
Link to PubMed
Lipnick RJ, Buring JE, Hennekens CH, et al. Oral contraceptives and
breast cancer. A prospective cohort study. Jama. Jan 3 1986;255(1):5861.
Link to PubMed
Murray PP, Stadel BV, Schlesselman JJ. Oral contraceptive use in women
with a family history of breast cancer. Obstet Gynecol. Jun
1989;73(6):977-983.
Link to PubMed
Paul C, Skegg DC, Spears GF. Oral contraceptives and risk of breast
cancer. Int J Cancer. Sep 15 1990;46(3):366-373.
Link to PubMed
Schlesselman JJ. Cancer of the breast and reproductive tract in relation to
use of oral contraceptives. Contraception. Jul 1989;40(1):1-38.
Link to PubMed
Schlesselman JJ. Oral contraceptives and breast cancer. Am J Obstet
Gynecol. Oct 1990;163(4 Pt 2):1379-1387.
Link to PubMed
Schlesselman JJ. Net effect of oral contraceptive use on the risk of cancer
in women in the United States. Obstet Gynecol. May 1995;85(5 Pt 1):793801.
Link to PubMed
Schlesselman JJ, Stadel BV, Korper M, Yu W, Wingo PA. Breast cancer
detection in relation to oral contraception. J Clin Epidemiol. May
1992;45(5):449-459.
Link to PubMed
Shulman LP. Oral contraceptives. Risks. Obstet Gynecol Clin North Am.
Dec 2000;27(4):695-704, v-vi.
Link to PubMed
Skegg DC. Safety and efficacy of fertility-regulating methods: a decade of
research. Bull World Health Organ. 1999;77(9):713-721.
Link to PubMed
Skegg DC. Evaluating the safety of medicines, with particular reference to
contraception. Stat Med. Dec 15 2001;20(23):3557-3569.
Link to PubMed
Tzingounis V, Cardamakis E, Ginopoulos P, Argiropoulos G. Incidence of
benign and malignant breast disorders in women taking hormones
(contraceptive pill or hormonal replacement therapy). Anticancer Res.
Nov-Dec 1996;16(6C):3997-4000.
Link to PubMed
Wile AG, DiSaia PJ. Hormones and breast cancer. Am J Surg. Apr
1989;157(4):438-442.
Link to PubMed
Hormonal Contraception and Cancer Risks
CERVICAL CANCER
1.
Bertram CC. Evidence for practice: oral contraception and risk of cervical
cancer. J Am Acad Nurse Pract. Oct 2004;16(10):455-461.
Link to PubMed
2.
Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and
use of hormonal contraceptives: a systematic review. Lancet. Apr 5
2003;361(9364):1159-1167.
Link to PubMed
3.
Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J.
Clinical breast and pelvic examination requirements for hormonal
contraception: Current practice vs evidence. Jama. May 2
2001;285(17):2232-2239.
Link to PubMed
OVARIAN and ENDOMETRIAL CANCERS (RISK REDUCTION)
1.
2.
3.
4.
5.
6.
7.
8.
Backman T, Rauramo I, Jaakkola K, et al. Use of the levonorgestrelreleasing intrauterine system and breast cancer. Obstet Gynecol. Oct
2005;106(4):813-817.
Link to PubMed
Burkman RT, Collins JA, Shulman LP, Williams JK. Current perspectives
on oral contraceptive use. Am J Obstet Gynecol. Aug 2001;185(2
Suppl):S4-12.
Link to PubMed
Chiaffarino F, Pelucchi C, Parazzini F, et al. Reproductive and hormonal
factors and ovarian cancer. Ann Oncol. Mar 2001;12(3):337-341.
Link to PubMed
Deligeoroglou E, Michailidis E, Creatsas G. Oral contraceptives and
reproductive system cancer. Ann N Y Acad Sci. Nov 2003;997:199-208.
Link to PubMed
Friedenson B. A current perspective on genetic testing for breast and
ovarian cancer: the oral contraceptive decision. MedGenMed. Nov 2
2001;3(6):2.
Link to PubMed
Gast K, Snyder T. Combination oral contraceptives and cancer risk. Kans
Med. Jul 1990;91(7):201-208.
Link to PubMed
Narod SA, Risch H, Moslehi R, et al. Oral contraceptives and the risk of
hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study
Group. N Engl J Med. Aug 13 1998;339(7):424-428.
Link to PubMed
Ness RB, Grisso JA, Cottreau C, et al. Factors related to inflammation of
the ovarian epithelium and risk of ovarian cancer. Epidemiology. Mar
2000;11(2):111-117.
Link to PubMed
Hormonal Contraception and Cancer Risks
9.
10.
11.
12.
13.
14.
15.
Ness RB, Grisso JA, Klapper J, et al. Risk of ovarian cancer in relation to
estrogen and progestin dose and use characteristics of oral
contraceptives. SHARE Study Group. Steroid Hormones and
Reproductions. Am J Epidemiol. Aug 1 2000;152(3):233-241.
Link to PubMed
Ness RB, Grisso JA, Vergona R, Klapper J, Morgan M, Wheeler JE. Oral
contraceptives, other methods of contraception, and risk reduction for
ovarian cancer. Epidemiology. May 2001;12(3):307-312.
Link to PubMed
Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Hormonal
factors and the risk of invasive ovarian cancer: a population-based casecontrol study. Fertil Steril. Jul 2004;82(1):186-195.
Link to PubMed
Pike MC, Spicer DV. Hormonal contraception and chemoprevention of
female cancers. Endocr Relat Cancer. Jun 2000;7(2):73-83.
Link to PDF
Sanderson M, Williams MA, Weiss NS, Hendrix NW, Chauhan SP. Oral
contraceptives and epithelial ovarian cancer. Does dose matter? J Reprod
Med. Sep 2000;45(9):720-726.
Link to PubMed
Sturridge F, Guillebaud J. A risk-benefit assessment of the levonorgestrelreleasing intrauterine system. Drug Saf. Dec 1996;15(6):430-440.
Link to PubMed
Walker GR, Schlesselman JJ, Ness RB. Family history of cancer, oral
contraceptive use, and ovarian cancer risk. Am J Obstet Gynecol. Jan
2002;186(1):8-14.
Link to PubMed